ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Factors associated with occult ipsilateral and contralateral nodal metastasis in resectable lateralized laryngeal and hypopharyngeal malignancies.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe incidence of occult lymph node metastasis is high in cT4aN0 laryngeal and lateral hypopharyngeal cancers, and bilateral selective neck dissection (levels II–IV) is routinely performed for oncologic clearance. However, the risk, distribution, and determinants of occult contralateral nodal involvement remain incompletely characterised. This retrospective cohort study evaluates the incidence of occult lymph node metastasis, the nodal stations commonly involved, and clinicopathological factors associated with contralateral occult nodal metastasis in patients with cT4aN0 laryngeal and lateral hypopharyngeal cancers.
methodsThe retrospective chart review spanned from January 2018 to December 2023, encompassing all patients who underwent total laryngectomy.150 patients with clinico-radiologically confirmed T4aN0 status and who underwent bilateral selective neck dissection (level II-IV) were included in analysis. A descriptive pathological study was performed to assess occult nodal distribution in resectable lateralised laryngeal and hypopharyngeal malignancies.
resultsThe incidence of occult lymph node metastasis was 28% (n = 42/150). The most commonly involved lymph node stations were level II (85.7%; N = 36/42) followed by level III (42.8%; N = 18/42) and level IV (9.5%; N = 4/42). pN1 disease was seen in 64.2% (n = 27/42) and multiple occult nodes (pN2) were seen in 35.8% cases. The incidence of contralateral occult lymph metastasis was found to be 11.9% (n = 5/42). The pyriform sinus (OR = 2.922, p = 0.014) and epiglottis involvement (OR = 3.615, p = 0.006) were significantly associated with higher nodal positivity odds, while subglottic extension showed increased odds without reaching statistical significance (OR = 2.174, p = 0.083). Subglottic extension was exploratively associated with the likelihood of contralateral nodal involvement (p = 0.004).
conclusionThe risk of occult lymph metastasis in clinico-radiologically cT4N0 laryngeal and lateralised hypo pharyngeal malignancies is high(28%) and statistically significant association is seen with epiglottic and pyriform sinus involvement. The association of contralateral occult lymph node metastasis with subglottic extension need further validation. LEVEL OF EVIDENCE: Level 4.
Indexed as
Identifiers
41699250What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.